X-151180104-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 0P and 5B. BP4BS2
The NM_004224.3(GPR50):c.521G>A(p.Arg174His) variant causes a missense change. The variant allele was found at a frequency of 0.000533 in 1,206,932 control chromosomes in the GnomAD database, including 2 homozygotes. There are 185 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00030 ( 0 hom., 5 hem., cov: 22)
Exomes 𝑓: 0.00056 ( 2 hom. 180 hem. )
Consequence
GPR50
NM_004224.3 missense
NM_004224.3 missense
Scores
1
5
11
Clinical Significance
Conservation
PhyloP100: 4.20
Genes affected
GPR50 (HGNC:4506): (G protein-coupled receptor 50) This gene product belongs to the G-protein coupled receptor 1 family. Even though this protein shares similarity with the melatonin receptors, it does not bind melatonin, however, it inhibits melatonin receptor 1A function through heterodimerization. Polymorphic variants of this gene have been associated with bipolar affective disorder in women. [provided by RefSeq, Jan 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -5 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.28187895).
BS2
High Hemizygotes in GnomAd4 at 5 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GPR50 | NM_004224.3 | c.521G>A | p.Arg174His | missense_variant | 2/2 | ENST00000218316.4 | NP_004215.2 | |
GPR50 | XM_011531216.3 | c.1+12G>A | intron_variant | XP_011529518.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GPR50 | ENST00000218316.4 | c.521G>A | p.Arg174His | missense_variant | 2/2 | 1 | NM_004224.3 | ENSP00000218316.3 |
Frequencies
GnomAD3 genomes AF: 0.000297 AC: 33AN: 110979Hom.: 0 Cov.: 22 AF XY: 0.000150 AC XY: 5AN XY: 33247
GnomAD3 genomes
AF:
AC:
33
AN:
110979
Hom.:
Cov.:
22
AF XY:
AC XY:
5
AN XY:
33247
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000133 AC: 24AN: 180467Hom.: 0 AF XY: 0.0000903 AC XY: 6AN XY: 66469
GnomAD3 exomes
AF:
AC:
24
AN:
180467
Hom.:
AF XY:
AC XY:
6
AN XY:
66469
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000557 AC: 610AN: 1095953Hom.: 2 Cov.: 33 AF XY: 0.000498 AC XY: 180AN XY: 361551
GnomAD4 exome
AF:
AC:
610
AN:
1095953
Hom.:
Cov.:
33
AF XY:
AC XY:
180
AN XY:
361551
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000297 AC: 33AN: 110979Hom.: 0 Cov.: 22 AF XY: 0.000150 AC XY: 5AN XY: 33247
GnomAD4 genome
AF:
AC:
33
AN:
110979
Hom.:
Cov.:
22
AF XY:
AC XY:
5
AN XY:
33247
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
4
ALSPAC
AF:
AC:
0
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
4
ExAC
AF:
AC:
15
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 16, 2024 | The c.521G>A (p.R174H) alteration is located in exon 2 (coding exon 2) of the GPR50 gene. This alteration results from a G to A substitution at nucleotide position 521, causing the arginine (R) at amino acid position 174 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Uncertain
D
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T
M_CAP
Benign
D
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M
PrimateAI
Benign
T
PROVEAN
Pathogenic
D
REVEL
Benign
Sift
Benign
T
Sift4G
Uncertain
D
Polyphen
B
Vest4
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at